The information in this website is intended only for healthcare professionals. By entering this site, you are confirming that you are a healthcare professional.
The information in this website is intended only for laboratory professionals. By entering this site, you are confirming that you are a laboratory professional.
Reduce hands-on time and improve workflowRead More
Systems to support the diagnosis of allergy, asthma and autoimmune diseasesRead More
Provide information to help assess risk for reaction and symptoms due to cross-reactivity.Read More
Access to enhanced functionality tests and methods, and moreRead More
Allergy & autoimmunity on one platformRead More
Your laboratory is at the heart of our innovation and productivityRead More
More than stiffness and swellingRead More
Managing allergy-induced asthma starts with identificationRead More
Request on coupling of new allergensRead More
Requirements for quality and competence among medical laboratoriesRead More
ImmunoCAP™ Allergen Components, which are purified native or recombinant proteins, offer the opportunity to assess a person's allergen sensitization pattern at the molecular level. Different component groups often elicit different types of reactions, so testing them can indicate if a patient's prior symptoms or positive test results were caused by allergy to a given substance or by a cross-reaction with another allergen. Test results with allergen components also help the clinician weigh a patient's risk of systemic reaction versus a more mild or localized response.
Canonica GW, Ansotegui IJ, Pawankar R, et al. A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17.